THERAPEUTIC CLASS
The safety of antithrombotic therapy in patients with cerebral microbleeds and cardiogenic cerebral embolism due to nonvalvular atrial fibrillation
The impact of cerebral microbleeds on the safety of antithrombotic therapy has recently received
considerable attention. We investigated the safety of antithrombotic therapy in patients with cerebral microbleeds
and cardiogenic cerebral embolism caused by nonvalvular atrial fibrillation
No other version available